Chronic Kidney Disease Awareness Campaign and Mobile Health Education to Improve Knowledge, Quality of Life, and Motivation for a Healthy Lifestyle Among Patients With Chronic Kidney Disease in Bangladesh: Randomized Controlled Trial

Mohammad Habibur Rahman Sarker, Michiko Moriyama, Harun Ur Rashid, Md Moshiur Rahman, Mohammod Jobayer Chisti, Sumon Kumar Das, Samir Kumar Saha, Shams El Arifeen, Tahmeed Ahmed, A S G Faruque, Mohammad Habibur Rahman Sarker, Michiko Moriyama, Harun Ur Rashid, Md Moshiur Rahman, Mohammod Jobayer Chisti, Sumon Kumar Das, Samir Kumar Saha, Shams El Arifeen, Tahmeed Ahmed, A S G Faruque

Abstract

Background: Chronic kidney disease (CKD) is linked to major health consequences and a poor quality of life. Despite the fact that CKD is becoming more prevalent, public knowledge of the disease remains low.

Objective: This study aimed to evaluate the outcome of a health education intervention designed to enhance knowledge, health-related quality of life (QOL), and motivation about healthy lifestyle among adults with CKD.

Methods: This study was a parallel-group (1:1), randomized controlled trial in the Mirzapur subdistrict of Bangladesh that compared 2 groups of patients with CKD. Adults with CKD (stages 1-3) were enrolled in November 2020 and randomly assigned the intervention or control group. The intervention group received health education through a CKD awareness campaign and mobile health technologies and was observed for 6 months, whereas the control group received standard treatment. The primary outcome was the evaluation of improved scores on the CKD knowledge questionnaire, and the secondary outcomes were improved QOL and changes in the levels of blood pressure (BP), BMI, serum creatinine, fasting blood sugar (FBS), hemoglobin, cholesterol, high-density lipoprotein cholesterol, triglyceride, serum uric acid, blood urea nitrogen (BUN), and albumin-to-creatinine ratio.

Results: The study enrolled 126 patients (control: n=63; intervention: n=63) and performed intention-to-treat analysis. The analyses included repeated measures ANOVA, and the results were observed to be significantly different from within groups (P<.001), between groups (P<.001), and the interaction of group × time factor (P<.001) for knowledge score. Diastolic BP and BMI showed significant differences arising from within groups (P<.001 and P=.01, respectively) and the interaction of group × time factor (P=.001 and P=.02, respectively); food salinity and hip circumferences showed significant differences arising from within groups (P=.001 and P=.03, respectively) and between groups (P=.001 and P=.02, respectively). Moreover, systolic BP and waist circumference showed significant differences from within groups (P<.001 and P=.003, respectively). However, no significant differences were found arising from within groups, between groups, and the interactions of group × time for QOL, urine salinity, and mid-upper arm circumference. Regarding the laboratory findings, from baseline to 6 months, the mean (SD) FBS decreased by 0.51 (3.77) mmol/L in the intervention group and 0.10 (1.44) mmol/L in the control group (P=.03); however, blood urea nitrogen increased by 3.64 (7.17) mg/dL in the intervention group and 1.68 (10.10) mg/dL in the control group (P=.01).

Conclusions: The health education strategy, which included a campaign and mobile health, showed promise for enhancing CKD knowledge among patients with CKD. This strategy may also aid patients with CKD in controlling their FBS and BP. The combined health education initiatives give evidence for scaling them up in Bangladesh and possibly other low- and middle-income countries, particularly in rural and peri-urban settings.

Trial registration: ClinicalTrials.gov NCT04094831; https://ichgcp.net/clinical-trials-registry/NCT04094831.

International registered report identifier (irrid): RR2-10.2196/30191.

Keywords: Bangladesh; LMIC; RCT; campaign; chronic condition; chronic disease; chronic kidney disease; health education; health knowledge; kidney; knowledge; low- and middle-income countries; mHealth; mobile health; motivation; patient education; patient knowledge; quality of life; randomized controlled trial.

Conflict of interest statement

Conflicts of Interest: None declared.

©Mohammad Habibur Rahman Sarker, Michiko Moriyama, Harun Ur Rashid, Md Moshiur Rahman, Mohammod Jobayer Chisti, Sumon Kumar Das, Samir Kumar Saha, Shams El Arifeen, Tahmeed Ahmed, A S G Faruque. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 11.08.2022.

Figures

Figure 1
Figure 1
Flowchart of the participants throughout the study. CKD: chronic kidney disease.

References

    1. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011 Dec;80(12):1258–70. doi: 10.1038/ki.2011.368. S0085-2538(15)55004-7
    1. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ. 2018 Jun 01;96(6):414–422D. doi: 10.2471/BLT.17.206441. BLT.17.206441
    1. GBD Chronic Kidney Disease Collaboration Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709–733. doi: 10.1016/S0140-6736(20)30045-3. S0140-6736(20)30045-3
    1. Varma PP. Prevalence of chronic kidney disease in India - where are we heading? Indian J Nephrol. 2015;25(3):133–5.
    1. Sarker MHR, Moriyama M, Rashid HU, Chisti MJ, Rahman MM, Das SK, Uddin A, Saha SK, Arifeen SE, Ahmed T, Faruque A. Community-based screening to determine the prevalence, health and nutritional status of patients with CKD in rural and peri-urban Bangladesh. Ther Adv Chronic Dis. 2021;12:20406223211035281. doi: 10.1177/20406223211035281. 10.1177_20406223211035281
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Chapter 1: definition and classification of CKD. Kidney Int Suppl (2011) 2013 Jan;3(1):19–62. doi: 10.1038/kisup.2012.64. S2157-1716(15)31101-1
    1. Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013 Jun 04;158(11):825–30. doi: 10.7326/0003-4819-158-11-201306040-00007. 1691737
    1. George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health. 2017;2(2):e000256. doi: 10.1136/bmjgh-2016-000256. bmjgh-2016-000256
    1. Vallianou NG, Mitesh S, Gkogkou A, Geladari E. Chronic kidney disease and cardiovascular disease: is there any relationship? Curr Cardiol Rev. 2019;15(1):55–63. doi: 10.2174/1573403X14666180711124825. CCR-EPUB-91636
    1. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019 Oct 01;322(13):1294–1304. doi: 10.1001/jama.2019.14745. 2752067
    1. Narva AS, Norton JM, Boulware LE. Educating patients about CKD: the path to self-management and patient-centered care. Clin J Am Soc Nephrol. 2016 Apr 07;11(4):694–703. doi: 10.2215/CJN.07680715. CJN.07680715
    1. Rawal L, Jubayer S, Choudhury SR, Islam SMS, Abdullah AS. Community health workers for non-communicable diseases prevention and control in Bangladesh: a qualitative study. Glob Health Res Policy. 2020 Dec 24;6(1):1. doi: 10.1186/s41256-020-00182-z. 10.1186/s41256-020-00182-z
    1. Gamage DG, Riddell MA, Joshi R, Thankappan KR, Chow CK, Oldenburg B, Evans RG, Mahal AS, Kalyanram K, Kartik K, Suresh O, Thomas N, Mini GK, Maulik PK, Srikanth VK, Arabshahi S, Varma RP, Guggilla RK, D'Esposito F, Sathish T, Alim M, Thrift AG. Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: a cluster randomised controlled trial. PLoS Med. 2020 Jan;17(1):e1002997. doi: 10.1371/journal.pmed.1002997. PMEDICINE-D-19-01554
    1. Jahan Y, Rahman MM, Faruque ASG, Chisti MJ, Kazawa K, Matsuyama R, Moriyama M. Awareness development and usage of mobile health technology among individuals with hypertension in a rural community of Bangladesh: randomized controlled trial. J Med Internet Res. 2020 Dec 07;22(12):e19137. doi: 10.2196/19137. v22i12e19137
    1. Tuot DS, Boulware LE. Telehealth applications to enhance CKD knowledge and awareness among patients and providers. Adv Chronic Kidney Dis. 2017 Jan;24(1):39–45. doi: 10.1053/j.ackd.2016.11.017. S1548-5595(16)30145-8
    1. Tangri N, Stevens Lesley A, Griffith John, Tighiouart Hocine, Djurdjev Ognjenka, Naimark David, Levin Adeera, Levey Andrew S. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011 Apr 20;305(15):1553–9. doi: 10.1001/jama.2011.451.jama.2011.451
    1. Wagner M, Wanner C, Schich M, Kotseva K, Wood D, Hartmann K, Fette G, Rücker Viktoria, Oezkur M, Störk Stefan, Heuschmann PU. Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey. BMC Nephrol. 2017 Oct 25;18(1):321. doi: 10.1186/s12882-017-0730-3. 10.1186/s12882-017-0730-3
    1. Finkelstein FO, Story K, Firanek C, Barre P, Takano T, Soroka S, Mujais S, Rodd K, Mendelssohn D. Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies. Kidney Int. 2008 Nov;74(9):1178–84. doi: 10.1038/ki.2008.376. S0085-2538(15)53493-5
    1. Zimbudzi E, Lo C, Ranasinha S, Kerr PG, Usherwood T, Cass A, Fulcher GR, Zoungas S. Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL. J Diabetes Complications. 2017 Feb;31(2):427–432. doi: 10.1016/j.jdiacomp.2016.10.027.S1056-8727(16)30392-0
    1. Grant S, Mayo-Wilson E, Montgomery P, Macdonald G, Michie S, Hopewell S, Moher D, CONSORT-SPI Group CONSORT-SPI 2018 explanation and elaboration: guidance for reporting social and psychological intervention trials. Trials. 2018 Jul 31;19(1):406. doi: 10.1186/s13063-018-2735-z. 10.1186/s13063-018-2735-z
    1. Chan A, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche Peter C, Krleža-Jerić K, Hróbjartsson Asbjørn, Mann H, Dickersin K, Berlin JA, Doré Caroline J, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 05;158(3):200–7. doi: 10.7326/0003-4819-158-3-201302050-00583. 1556168
    1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, van Lente Frederick, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009 May 05;150(9):604–12. doi: 10.7326/0003-4819-150-9-200905050-00006. 150/9/604
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021 Mar;99(3S):S1–S87. doi: 10.1016/j.kint.2020.11.003. S0085-2538(20)31270-9
    1. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014 May;63(5):713–35. doi: 10.1053/j.ajkd.2014.01.416.S0272-6386(14)00491-0
    1. Sarker MHR, Moriyama M, Rashid HU, Rahman MM, Chisti MJ, Das SK, Jahan Y, Saha SK, Arifeen SE, Ahmed T, Faruque ASG. Health education through a campaign and mHealth to enhance knowledge and quality of life among patients with chronic kidney disease in Bangladesh: protocol for a randomized controlled trial. JMIR Res Protoc. 2021 Nov 19;10(11):e30191. doi: 10.2196/30191. v10i11e30191
    1. Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL. Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health. 2018 Mar 20;18(1):371. doi: 10.1186/s12889-018-5301-4. 10.1186/s12889-018-5301-4
    1. van Hout Ben, Janssen MF, Feng Y, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–15. doi: 10.1016/j.jval.2012.02.008. S1098-3015(12)00058-7
    1. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011 Dec;20(10):1727–36. doi: 10.1007/s11136-011-9903-x.
    1. Lachin JM. Fallacies of last observation carried forward analyses. Clin Trials. 2016 Apr;13(2):161–8. doi: 10.1177/1740774515602688. 1740774515602688
    1. Thondoo M, Strachan DL, Nakirunda M, Ndima S, Muiambo A, Källander Karin, Hill Z, InSCALE Study Group Potential roles of mHealth for community health workers: formative research with end users in Uganda and Mozambique. JMIR mHealth uHealth. 2015 Jul 23;3(3):e76. doi: 10.2196/mhealth.4208. v3i3e76
    1. Javanparast S, Windle A, Freeman T, Baum F. Community health worker programs to improve healthcare access and equity: are they only relevant to low- and middle-income countries? Int J Health Policy Manag. 2018 Oct 01;7(10):943–954. doi: 10.15171/ijhpm.2018.53.
    1. Verberk WJ, Kroon AA, Lenders JWM, Kessels AGH, van Montfrans GA, Smit AJ, van der Kuy PM, Nelemans PJ, Rennenberg RJMW, Grobbee DE, Beltman FW, Joore MA, Brunenberg DEM, Dirksen C, Thien T, de Leeuw PW, Home Versus Office Measurement‚ Reduction of Unnecessary Treatment Study Investigators Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension. 2007 Dec;50(6):1019–25. doi: 10.1161/HYPERTENSIONAHA.107.094193.HYPERTENSIONAHA.107.094193
    1. McDuffie RH, Struck L, Burshell A. Empowerment for diabetes management: integrating true self-management into the medical treatment and management of diabetes mellitus. Ochsner J. 2001 Jul;3(3):149–57.
    1. Chen S, Qian D, Burström Kristina, Burström Bo. Impact of an educational intervention in primary care on fasting blood glucose levels and diabetes knowledge among patients with type 2 diabetes mellitus in rural China. Patient Educ Couns. 2020 Sep;103(9):1767–1773. doi: 10.1016/j.pec.2020.03.010. S0738-3991(20)30144-0
    1. Kim HJ, Kim TE, Han M, Yi Y, Jeong JC, Chin HJ, Song SH, Lee J, Lee K, Sung S, Han SH, Seong EY, Ahn C, Oh K, Chae D. Effects of blood urea nitrogen independent of the estimated glomerular filtration rate on the development of anemia in non-dialysis chronic kidney disease: the results of the KNOW-CKD study. PLoS One. 2021;16(9):e0257305. doi: 10.1371/journal.pone.0257305. PONE-D-20-41118

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi